Cannabidiol in autism: Clinical pharmacology priorities for trial design
Cannabidiol in autism: Clinical pharmacology priorities for trial design is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cannabidiol in autism: Clinical pharmacology priorities for trial design have?
Cannabidiol in autism: Clinical pharmacology priorities for trial design has 1 citations in the OpenAlex counts ScholarIQ stores.
When was Cannabidiol in autism: Clinical pharmacology priorities for trial design published?
Cannabidiol in autism: Clinical pharmacology priorities for trial design has 2025 year in the ScholarIQ index.
What is the open-access status of Cannabidiol in autism: Clinical pharmacology priorities for trial design?
Cannabidiol in autism: Clinical pharmacology priorities for trial design has hybrid oa status in the ScholarIQ index.
What is the DOI of Cannabidiol in autism: Clinical pharmacology priorities for trial design?
The DOI for Cannabidiol in autism: Clinical pharmacology priorities for trial design is on the source record.
What is the PMID of Cannabidiol in autism: Clinical pharmacology priorities for trial design?
The PMID for Cannabidiol in autism: Clinical pharmacology priorities for trial design is on the source record.
What is the OpenAlex record for Cannabidiol in autism: Clinical pharmacology priorities for trial design?
The OpenAlex for Cannabidiol in autism: Clinical pharmacology priorities for trial design is on the source record.